Londinia Opportunities Analyses - 12/02/2021 (GMT) ACACIA PHARMA - 1H
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
- Europe Stocks
- Timeframe : 1H
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Trends
Short term:
Strongly bearish
Underlying:
Strongly bearish
Technical indicators
11%
72%
17%
My opinion
Bearish under 1.370 EUR
My targets
1.241 EUR (-5.24%)
1.123 EUR (-14.30%)
My analysis
ACACIA PHARMA is part of a very strong bearish trend. Traders may consider trading only short positions (for sale) as long as the price remains well below 1.370 EUR. The next support located at 1.241 EUR is the next bearish objective to target. A bearish break of this support would revive the bearish momentum. The bearish movement could then continue towards the next support located at 1.123 EUR. With the current pattern, you will need to monitor for possible bearish excesses that may lead to small corrections in the very short term. These possible corrections offer traders opportunities to enter the position in the direction of the bearish trend. Trying to profit from the purchase of these possible corrections may seem risky.
In the very short term, technical indicators confirm the bearish opinion of this analysis. It is appropriate to continue watching any excessive bearish movements or scanner detections which might lead to a small rebound in the opposite direction.
Force
0
10
8
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
Additional analysis
Quotes
The ACACIA PHARMA price is 1.310 EUR. The price is lower by -3.82% since the last closing and was traded between 1.300 EUR and 1.364 EUR over the period. The price is currently at +0.77% from its lowest and -3.96% from its highest.1.300
1.364
1.310
The Central Gaps scanner detects the formation of a bearish gap marking the strong presence of sellers ahead of buyers at the opening. This formed a quotation gap.
Opening Gap DOWN
Type : Bearish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
New LOW record (1st january)
Type : Bearish
Timeframe : Weekly
New LOW record (1 month)
Type : Bearish
Timeframe : Weekly
Technical
Technical analysis of this 1H chart of ACACIA PHARMA indicates that the overall trend is strongly bearish. 92.86% of the signals given by moving averages are bearish. This strongly bearish trend is supported by the strong bearish signals given by short-term moving averages. There is no crossing of moving average by the price or crossing of moving averages between themselves.
Technical indicators are strongly bearish, suggesting that the price decline is expected to continue.
Caution: the Central Indicators scanner currently detects an excess:
CCI indicator is oversold : under -100
Type : Neutral
Timeframe : 1 hour
Williams %R indicator is oversold : under -80
Type : Neutral
Timeframe : 1 hour
Pivot points : price is under support 1
Type : Neutral
Timeframe : Weekly
Pivot points : price is under support 3
Type : Neutral
Timeframe : 1 hour
Central Patterns, the market scanner focusing on chart patterns, resistances and supports found these results:
Near horizontal support
Type : Bullish
Timeframe : 1 hour
Support of channel is broken
Type : Bearish
Timeframe : 1 hour
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
ProTrendLines
S1
R1
R2
R3
Price
| S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|
| ProTrendLines | 1.308 | 1.310 | 1.370 | 1.460 | 1.530 |
| Change (%) | -0.15% | - | +4.58% | +11.45% | +16.79% |
| Change | -0.002 | - | +0.060 | +0.150 | +0.220 |
| Level | Intermediate | - | Intermediate | Intermediate | Minor |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 1.295 | 1.323 | 1.343 | 1.371 | 1.391 | 1.419 | 1.439 |
| Camarilla | 1.349 | 1.353 | 1.358 | 1.362 | 1.366 | 1.371 | 1.375 |
| Woodie | 1.290 | 1.321 | 1.338 | 1.369 | 1.386 | 1.417 | 1.434 |
| Fibonacci | 1.323 | 1.342 | 1.353 | 1.371 | 1.390 | 1.401 | 1.419 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 1.123 | 1.241 | 1.311 | 1.429 | 1.499 | 1.617 | 1.687 |
| Camarilla | 1.328 | 1.346 | 1.363 | 1.380 | 1.397 | 1.415 | 1.432 |
| Woodie | 1.098 | 1.229 | 1.286 | 1.417 | 1.474 | 1.605 | 1.662 |
| Fibonacci | 1.241 | 1.313 | 1.358 | 1.429 | 1.501 | 1.546 | 1.617 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 0.913 | 1.137 | 1.249 | 1.473 | 1.585 | 1.809 | 1.921 |
| Camarilla | 1.270 | 1.300 | 1.331 | 1.362 | 1.393 | 1.424 | 1.454 |
| Woodie | 0.858 | 1.109 | 1.194 | 1.445 | 1.530 | 1.781 | 1.866 |
| Fibonacci | 1.137 | 1.265 | 1.344 | 1.473 | 1.601 | 1.680 | 1.809 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 29.39 | |
| MACD (12,26,9): | -0.0200 | |
| Directional Movement: | -22.885 | |
| AROON (14): | -100.000 | |
| DEMA (21): | 1.324 | |
| Parabolic SAR (0,02-0,02-0,2): | 1.374 | |
| Elder Ray (13): | -0.031 | |
| Super Trend (3,10): | 1.361 | |
| Zig ZAG (10): | 1.302 | |
| VORTEX (21): | 0.7880 | |
| Stochastique (14,3,5): | 4.58 | |
| TEMA (21): | 1.316 | |
| Williams %R (14): | -100.00 | |
| Chande Momentum Oscillator (20): | -0.076 | |
| Repulse (5,40,3): | -2.6400 | |
| ROCnROLL: | 2 | |
| TRIX (15,9): | -0.1520 | |
| Courbe Coppock: | 7.19 |
| MA7: | 1.373 | |
| MA20: | 1.490 | |
| MA50: | 1.692 | |
| MA100: | 1.975 | |
| MAexp7: | 1.324 | |
| MAexp20: | 1.349 | |
| MAexp50: | 1.380 | |
| MAexp100: | 1.425 | |
| Price / MA7: | -4.59% | |
| Price / MA20: | -12.08% | |
| Price / MA50: | -22.58% | |
| Price / MA100: | -33.67% | |
| Price / MAexp7: | -1.06% | |
| Price / MAexp20: | -2.89% | |
| Price / MAexp50: | -5.07% | |
| Price / MAexp100: | -8.07% |
Quotes :
-
15 min delayed data
-
Euronext Bruxelles
News
The last news published on ACACIA PHARMA at the time of the generation of this analysis was as follows:
- Acacia Pharma to Present at the Jefferies London Healthcare Conference
- Interim Results for the Six Months ended 30 June 2021 - Barhemsys® and Byfavo® Launches Continue to Achieve Strong Hospital Formulary Adoption
- Acacia Pharma Announces Submission and Validation of Marketing Authorization Application for BARHEMSYS® (amisulpride injection) in Major European Markets
- Correction: Notice of Results
- Notice of Results